ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
// Xiaoye Liu 1,2,3,* , Xiaoting Yu 4,* , Jingjing Xie 5 , Mengna Zhan 6 , Zhuo Yu 3 , Li Xie 3 , Hongxiang Zeng 3 , Feifei Zhang 3 , Guoqiang Chen 1,3 , Xianghua Yi 4 and Junke Zheng 2,3 1 Institute of Health Sciences, Shanghai Institute for Biological Sciences, University of Chinese Academy of Science, Chinese Academy of Sciences and Shanghai Jiao Tong University School of Medicine, Shanghai, China 2 Hongqiao International Institute of Medicine, Shanghai Tongren Hospital, Faculty of Basic Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China 3 Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, China 4 Department of Pathology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China 5 Bingzhou Medical University, Taishan Scholar Program, Yantai, China 6 Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China * These authors have contributed equally to this paper Correspondence to: Junke Zheng, email: // Xianghua Yi, email: // Guoqiang Chen, email: // Keywords : ANGPTL2/LILRB2 signaling, lung cancer, metastasis, CaMK1 Received : December 31, 2014 Accepted : May 10, 2015 Published : May 20, 2015 Abstract Immune inhibitory receptors expressed on various types of immune cells deliver inhibitory signals that maintain the homeostasis of the immune system. Recently we demonstrated that leukocyte immunoglobulin-like receptor subfamily B member 2 (LILRB2) and its murine homolog, paired immunoglobulin-like receptor B (PIRB), are expressed on hematopoietic stem cells and acute myeloid leukemia stem cells and function in maintenance of stemness. Herein, we determined that both LILRB2 and its soluble ligand ANGPTL2 are highly expressed in non-small cell lung cancer (NSCLC) samples, and levels are adversely related to patient prognosis. Inhibition of LILRB2 expression in NSCLC cell lines, such as A549 cells, resulted in a dramatic decrease in proliferation, colony formation, and migration. Mechanistic analyses indicated that ANGPTL2 binds LILRB2 to support the growth of lung cancer cells and that the SHP2/CaMK1/CREB axis controls the proliferation of lung cancer cell lines. Our results suggest that signaling involving ANGPTL2 and LILRB2 is important for lung cancer development and represents a novel target for treatment of this type of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zhang, H., Wong, C. C. L., Wei, H., Gilkes, D. M., Korangath, P., Chaturvedi, P., Schito, L., Chen, J., Krishnamachary, B., Winnard, P. T., et al. (2012) · Oncogene · doi:10.1038/onc.2011.365 · Cited by 326 · cited 1×
“ANGPTL4 promotes metastasis in several types of cancers including breast cancers and esophageal squamous cell carcinoma [36, 18], but the surface receptor for ANGPTL4 remains unknown.”
RetractedSuppression of lung adenocarcinoma progression by Nkx2-1
Winslow, M. M., Dayton, T. L., Verhaak, R. G. W., Kim-Kiselak, C., Snyder, E. L., Feldser, D. M., Hubbard, D. D., DuPage, M. J., Whittaker, C. A., Hoersch, S., et al. (2011) · Nature · doi:10.1038/nature09881 · Cited by 467
Köster, A., Chao, Y. B., Mosior, M., Ford, A., Gonzalez-DeWhitt, P. A., Hale, J. E., Li, D., Qiu, Y., Fraser, C. C., Yang, D. D., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0476 · Cited by 427 · cited 1×
“Similarly, ANGPTLs have been demonstrated to play crucial roles in lipid metabolism and angiogenesis [34, 16, 35], and our previous study showed that LILRB2 inhibits differentiation and promotes self-renewal of HSCs and LSCs; however, the function of LILRB2 in cancer progression remains unclear.”
The Role of Angiopoietin-Like Proteins in Angiogenesis and Metabolism
Hato, T., Tabata, M., & Oike, Y. (2008) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2007.10.003 · Cited by 351 · cited 2×
“ANGPTLs are a family of secreted glycoproteins that have the same domain structure as angiopoietins; members of both families have an N-terminal coiledcoil domain and a C-terminal fibrinogen-like domain [12].”
Cited by
Functions of Immune Checkpoint Molecules Beyond Immune Evasion
Zhang, Y., & Zheng, J. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-15-3266-5_9 · Cited by 260
Self-citationAngiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer
Carbone, C., Piro, G., Merz, V., Simionato, F., Santoro, R., Zecchetto, C., Tortora, G., & Melisi, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020431 · Cited by 200
LILRB receptor-mediated regulation of myeloid cell maturation and function
van der Touw, W., Chen, H.-M., Pan, P.-Y., & Chen, S.-H. (2017) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-017-2023-x · Cited by 167
Choi, H., Deng, J., Li, S., Silk, T., Dong, L., Brea, E. J., Houghton, S., Redmond, D., Zhong, H., Boiarsky, J., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.066 · Cited by 72
“Immunohistochemistry (IHC) staining and analyses—Paraffin-embedded sections were deparaffinized, followed by immunohistochemical staining with antibodies against pERK (Cell Signaling) and examined using a Leica upright microscope (Liu et al., 2015b).”
MethodAssessing Therapeutic Efficacy of MEK Inhibition in a KRASG12C-Driven Mouse Model of Lung Cancer
Li, S., Liu, S., Deng, J., Akbay, E. A., Hai, J., Ambrogio, C., Zhang, L., Zhou, F., Jenkins, R. W., Adeegbe, D. O., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3438 · Cited by 67
“Results were independently scored by two pathologists using multiplicative quick systems (33).”
MethodSelf-citation
Metadata
- Authors
- Liu, X., Yu, X., Xie, J., Zhan, M., Yu, Z., Xie, L., Zeng, H., Zhang, F., Chen, G., Yi, X., & Zheng, J.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2015-05-20
- Volume
- 6
- Issue
- 25
- Pages
- 21004-21015
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W1489345765
- Cited by
- 73
- References
- 4
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.